Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Summary

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have advanced solid tumors.

Timeline

Start

2002-02

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “Study was not successful at recruiting particpants”

Drugs

Indications